Heinrich Aschauer

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

Andreas Billich, Heinrich Aschauer, András Aszódi et al. · International Journal of Pharmaceutics · 2003 · 184 citations

Allergy, Atopic Dermatitis, Allergy Medicine +9

Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor

Hans Skvara, Frank Kalthoff, Josef G. Meingassner et al. · Journal of Investigative Dermatology · 2011 · 148 citations · Full text

Neuro-oncology, Smoothened Inhibitor, Dermatology +6

Expression of Epidermal Keratins and the Cornified Envelope Protein Involucrin is Influenced by Permeability Barrier Disruption

Swarna Ekanayake‐Mudiyanselage, Jens‐Michael Jensen, Ehrhardt Proksch et al. · Journal of Investigative Dermatology · 1998 · 122 citations · Full text

Epidermal Keratins, Cutaneous Biology, Cell Adhesion +8

Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid‐pretreated skin

Josef G. Meingassner, Heinrich Aschauer, Anton Stuetz et al. · Experimental Dermatology · 2005 · 53 citations

Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases

David A. Sandham, Nicola Arnold, Heinrich Aschauer et al. · Bioorganic & Medicinal Chemistry · 2013 · 22 citations · Full text

Allergy, Clinical Testing, Medicine +8